Dr. Bobak Jason Akhavan, MD

Dr. Akhavan practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Akhavan's NPI, 1982099024, was assigned on April 6, 2015. Dr. Akhavan graduated from St. George's University School of Medicine in 2015. Dr. Akhavan holds California license A163091.

Dr. Akhavan's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Akhavan's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Akhavan is also affiliated with Cedars-Sinai Marina Hospital. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Akhavan to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akhavan practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Akhavan's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Akhavan is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Akhavan's licenses on file in 2 states: California and Texas.

Dmand AI lists chronic obstructive pulmonary disease (COPD), pulmonary fibrosis and sleep apnea among the conditions Dr. Akhavan treats.

CMS data shows 589 Medicare services from Dr. Akhavan across 9 procedure codes in 2024, for 221 Medicare patients. Medicare paid $91,773 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 221 Medicare patients who saw Dr. Akhavan in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 3.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Akhavan's median patient age at 67, with 44% women.

In 2024, Dr. Akhavan wrote 111 Medicare Part D claims for 26 patients. 73% of them were for generic drugs. CMS names the drug for 33 of them, across 2 drugs with 11 or more claims each, at $2,475 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Akhavan for performance year 2024, reported as part of a group. Dr. Akhavan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Akhavan as offering telehealth.

Dmand AI links 12 papers to Dr. Akhavan, published from 2017 to 2024. 2019 was the busiest year, with 4. The most frequent topics are Bacteremia, Blood Culture and Bronchoscopy. Dr. Akhavan has published most often in Clin Infect Dis. Dr. Akhavan's most frequent co-authors are Gabriel Marcelo Aisenberg, MD, Christina Nicole Canzoneri, MD and Zehra Tosur, MD.

CMS Open Payments shows 17 general payments to Dr. Akhavan from 4 drug and device companies from 2024 to 2025. Honoraria make up the largest share, 73% of the total. ANI Pharmaceuticals, Inc. paid the most, $6,424.

Dr. Akhavan graduated from St. George's University School of Medicine in 2015.

Dr. Akhavan is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.